Showing 1651-1660 of 2727 results for "".
- PLADUOpro Plasma System Debuts in North Americahttps://modernaesthetics.com/news/pladuopro-plasma-system-debuts-in-north-america/2483995/Aesthetic Management Partners (AMP) announced the North American launch of PLADUOpro, a dual-gas plasma device designed to support noninvasive skin resurfacing and regeneration. The device, which integrates both argon and nitro
- Mayo Clinic Researchers Develop Fully Humanized 3D Bioprinted Skin Using Plant-Based Collagenhttps://modernaesthetics.com/news/mayo-clinic-researchers-develop-fully-humanized-3d-bioprinted-skin-using-plant-based-collagen/2483984/Mayo Clinic scientists have developed a fully humanized 3D bioprinted skin model using recombinant human collagen (rhCollagen) derived from plants, according to a study published in Archives of Dermatological Research.
- BTL Files Patent Infringement Lawsuit Against WonderFace Devicehttps://modernaesthetics.com/news/btl-files-patent-infringement-lawsuit-against-wonderface-device/2483957/BTL Group has filed a patent infringement claim before the Unified Patent Court against Lexter Microelectronic Engineering Systems S.L., the company behind the WonderFace device. The claim centers on BTL’s proprietary technology used in its EMFACE system, which integrates selective muscle
- Natural Refinement, Early Intervention Define 2026 Aesthetic Trends, Says Dr Anil Shahhttps://modernaesthetics.com/news/natural-refinement-early-intervention-define-2026-aesthetic-trends-says-dr-anil-shah/2483940/Facial plastic surgeon Anil Shah, MD, outlined six key trends shaping aesthetic surgery in 2026 in a recent press release, reflecting a shift toward holistic, age-conscious, and safety-driven approaches. A full-face rejuvenation approach is supplanting isolated interventions, according to
- GLP-1 Demand Holds Steady in Aesthetic Clinics Despite Regulatory Shiftshttps://modernaesthetics.com/news/glp-1-demand-holds-steady-in-aesthetic-clinics-despite-regulatory-shifts/2483599/Despite regulatory uncertainty and reported shortages, aesthetic practices continue to experience high demand for glucagon-like peptide-1 (GLP-1) receptor agonists, according to a report released by Guidepoint Qsight on October 1, 2025.
- Dr. Anthony Brissett Named President of AAFPRS for 2025–2026 Termhttps://modernaesthetics.com/news/dr-anthony-brissett-named-president-of-aafprs/2483515/Anthony E. Brissett, MD, FACS, a facial plastic and reconstructive surgeon based in Houston, has been named President of the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) for the 2025–2026 term. His appointment was formalized during the AAFPRS Annual Business Meeting held
- Daxxify® Surpasses 1 Million Vials Distributed in US Aesthetic Markethttps://modernaesthetics.com/news/daxxify-surpasses-1-million-vials-distributed-in-us-aesthetic-market/2483419/Revance Therapeutics has announced the distribution of more than 1 million vials of daxibotulinumtoxinA-lanm (Daxxify®) for aesthetic use in the United States, marking a notable milestone 3 years after the product received US Food and Drug Administration (FDA) approval. According to a pres
- Neuvian Skincare Granted US Patent for Dual-Peptide Complexhttps://modernaesthetics.com/news/neuvian-skincare-granted-us-patent-for-dual-peptide-complex/2483373/Neuvian Skincare has received a US patent for its dual-peptide formulation targeting inflammatory skin conditions such as wounds, scars, and eczema, according to a press release. The patent (No. 12,377,156 B2), issued for “Compositions and Methods for Treatment of Wounds and Inflammatory Skin Con
- Device Manufacturer’s Initiative Offers Treatments to Support Firefighters’ Healthhttps://modernaesthetics.com/news/device-manufacturers-initiative-offers-treatments-to-support-firefighters-health/2483123/BTL Industries has launched a nationwide initiative aimed at addressing the mental and physical health challenges faced by firefighters, particularly those serving in high-risk wildfire regions. The program is framed under BTL’s Heros Deserve Healing campaign, which calls on clinicians an
- Amarte Relaunches Dermatologist-Formulated Ultra Veil Daily SPF 40https://modernaesthetics.com/news/amarte-relaunches-dermatologist-formulated-ultra-veil-daily-spf-40/2483103/Amarte Skin Care has relaunched its flagship sunscreen, ULTRA VEIL® DAILY SPF 40, according to a press release from the manufacturer. The updated product maintains its position as a top-tier hybrid sunscreen, the press release